Patent Assignment
Reel/Frame 045619/0257
CHANGE OF NAME
Recorded: 2018-03-16
Received: 2018-03-16
Pages: 8
Assignor
QLT INC.
Executed: 2016-11-29
Assignee
NOVELION THERAPEUTICS INC.
1800 - 510 WEST GEORGIA STREET, VANCOUVER, CAX, BC V6B 0M3, CANADA
Covered Applications
(5)
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/837,705
→
ENGINEERED POLYPEPTIDES HAVING ENHANCED DURATION OF ACTION
App. No. 14/800,537
→
A CHIMERIC LEPTIN POLYPEPTIDE AND METHOD OF USING THE SAME
App. No. 14/703,523
→
COMPOUND IMPURITIES AND METHODS OF DETECTING SAME
App. No. 62/154,906
→
ENGINEERED POYPEPTIDES HAVING ENHANCED DURATION OF ACTION AND REDUCED IMMUNOGENICITY
App. No. 14/129,793
→